Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications

by Ana Godoy-Ortiz, Ana Godoy-Ortiz, Alfonso Sanchez-Muñoz, Alfonso Sanchez-Muñoz, Maria Rosario Chica Parrado, Martina Álvarez, Nuria Ribelles, Nuria Ribelles, Antonio Rueda Dominguez, Antonio Rueda Dominguez, Emilio Alba, Emilio Alba, Emilio Alba
Published 2019-10-01

Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Stand...

by Tamara Díaz-Redondo, Tamara Díaz-Redondo, Rocio Lavado-Valenzuela, Rocio Lavado-Valenzuela, Begoña Jimenez, Begoña Jimenez, Tomas Pascual, Fernando Gálvez, Alejandro Falcón, Maria del Carmen Alamo, Cristina Morales, Marta Amerigo, Javier Pascual, Alfonso Sanchez-Muñoz, Alfonso Sanchez-Muñoz, Macarena González-Guerrero, Luis Vicioso, Luis Vicioso, Aurora Laborda, Maria Victoria Ortega, Maria Victoria Ortega, Lidia Perez, Lidia Perez, Aranzazu Fernandez-Martinez, Nuria Chic, Jose Manuel Jerez, Jose Manuel Jerez, Martina Alvarez, Martina Alvarez, Martina Alvarez, Aleix Prat, Nuria Ribelles, Nuria Ribelles, Emilio Alba, Emilio Alba, Emilio Alba
Published 2019-11-01